Who is the CEO of Astellas Pharma Inc.?

Mr. Naoki Okamura is the President of Astellas Pharma Inc., joining the firm since 2016.

What is the price performance of Astellas Pharma, Inc. stock?

The current price of Astellas Pharma, Inc. is $14.16, it has decreased 0% in the last trading day.

What are the primary business themes or industries for Astellas Pharma Inc.?

Astellas Pharma Inc. belongs to Pharmaceuticals industry and the sector is Health Care

What is Astellas Pharma Inc. market cap?

Astellas Pharma Inc.'s current market cap is $25.3B

Is Astellas Pharma Inc. a buy, sell, or hold?

According to wall street analysts, 18 analysts have made analyst ratings for Astellas Pharma Inc., including 3 strong buy, 5 buy, 11 hold, 1 sell, and 3 strong sell

Astellas Pharma Inc. (ALPMY) Stock Price, Chart, News and AI analysis



ALPMY

ALPMY Price

Astellas Pharma Inc.

$14.16

5.43%

$0.73

At close: May 29, 16:00:00 GMT-4

$14.16

Post-market: May 29, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$13.43

Open

$14.21

Day's Range

$14 - $14.24

52 week range

$9.11 - $17.35

Volume

9.8K

Avg.Volume

155.2K

Dividend yield

EPS (TTM)

1.02

Market Cap

$25.3B

What is Astellas Pharma, Inc.?

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To. The firm mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Features

Markets

News

Astellas Pharma Inc. (ALPMY) Price

ALPMY Stock Price Chart